Skip to main content

Suicide, Attempted

0
Pipeline Programs
5
Companies
5
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Alliance Pharmaceuticals
2 programs
Post Admission Cognitive TherapyN/A1 trial
To Share or Not to ShareN/A1 trial
Active Trials
NCT01340859Completed24Est. Dec 2018
NCT05018897Unknown120Est. Aug 2022
Utah Medical
Utah MedicalIreland - Dublin
1 program
Brief Cognitive Behavioral TherapyN/A1 trial
Active Trials
NCT03769259Enrolling By Invitation300Est. Aug 2025
Marius Pharmaceuticals
1 program
Interventional group : PEPSUI psychoeducational programN/A1 trial
Active Trials
NCT03185026Recruiting500Est. May 2026
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
1 program
WET-SPN/A1 trial
Active Trials
NCT05878795Recruiting160Est. Jun 2026

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Colorado TherapeuticsWET-SP
Alliance PharmaceuticalsTo Share or Not to Share
Utah MedicalBrief Cognitive Behavioral Therapy
Marius PharmaceuticalsInterventional group : PEPSUI psychoeducational program
Alliance PharmaceuticalsPost Admission Cognitive Therapy

Clinical Trials (5)

Total enrollment: 1,104 patients across 5 trials

NCT05878795Colorado TherapeuticsWET-SP

Written Exposure Therapy for Suicide Prevention

Start: Aug 2024Est. completion: Jun 2026160 patients
N/ARecruiting
NCT05018897Alliance PharmaceuticalsTo Share or Not to Share

Strategic Disclosure Intervention for Suicide Attempt Survivors

Start: Mar 2021Est. completion: Aug 2022120 patients
N/AUnknown
NCT03769259Utah MedicalBrief Cognitive Behavioral Therapy

Brief Cognitive Behavioral Therapy Replication Trial

Start: Jan 2020Est. completion: Aug 2025300 patients
N/AEnrolling By Invitation
NCT03185026Marius PharmaceuticalsInterventional group : PEPSUI psychoeducational program

Psychoeducation for Suicidal Behavior

Start: Sep 2017Est. completion: May 2026500 patients
N/ARecruiting
NCT01340859Alliance PharmaceuticalsPost Admission Cognitive Therapy

Inpatient Post Admission Cognitive Therapy (PACT) for the Prevention of Suicide Attempts

Start: Apr 2011Est. completion: Dec 201824 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 actively recruiting trials targeting 1,104 patients
5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.